Lung cancer: open trials in Norway

23 open trials have a site in Norway. Registry data; only the trial team decides who can take part.

NCT06119581
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Trial Treatment · Phase 3 · Eli Lilly and Company
Helse Bergen HF, Bergen · Vestre Viken HF, Drammen · Sykehuset Innlandet HF, Gjoevik · Akershus University Hospital, Loerenskog · Oslo University Hospital HF, Oslo · Helse Stavanger HF, Stavanger · St. Olavs hospital HF, Trondheim
Registry updated 2026-11-04
NCT06890598
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
Trial Treatment · Phase 3 · Eli Lilly and Company
Sorlandet Sykehus Arendal, Arendal · Haukeland Universitetssjukehus, Bergen · Drammen Sykehus, Vestre Viken HF, Drammen · Sykehuset Innlandet HF Gjøvik, Gjøvik · Oslo Universitetssykehus, Radiumhospitalet, Oslo
Registry updated 2026-11-04
NCT07492680
A Study of Navlimetostat (BMS-986504) Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
Trial Treatment · Phase 2 · Bristol-Myers Squibb
Haukeland Universitetssjukehus, Bergen · Oslo universitetssykehus HF, Ullevål, Oslo
Registry updated 2026-11-04
NCT04613596
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Trial Treatment · Phase 2/3 · Mirati Therapeutics Inc.
Vestre Viken HF, Drammen
Registry updated 2026-10-30
NCT07472517
DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy
Trial Treatment · Phase 3 · Boehringer Ingelheim
Helse Bergen HF, Bergen · Oslo Universitetssykehus HF, Oslo · St. Olavs hospital HF, Trondheim
Registry updated 2026-10-28
NCT07900724
New Smoking Cessation Intervention in Primary Care - a Randomized Controlled Trial
Trial Treatment · Helse Nord-Trøndelag HF
Levanger Hospital, Levanger
Registry updated 2026-10-28
NCT06172478
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Trial Treatment · Phase 2 · Daiichi Sankyo
Akershus universitetssykehus, Lørenskog · Haukeland universitetssjukehus, Lørenskog · Oslo Universitetssykehus HF, Radiumhospitalet, Oslo
Registry updated 2026-10-26
NCT07063745
A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion
Trial Treatment · Phase 2/3 · Bristol-Myers Squibb
Oslo Universitetssykehus HF, Oslo
Registry updated 2026-10-23
NCT07361510
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
Trial Treatment · Phase 3 · Bristol-Myers Squibb
Vestre Viken HF, Drammen · Sykehuset Ostfold HF, Graalum
Registry updated 2026-10-23
NCT06801834
Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer
Trial Treatment · Phase 3 · Gilead Sciences
Haukeland University Hospital, Bergen · Seksjon for kreftbehandling, Drammen Hospital, Drammen · Oslo University Hospital, Oslo
Registry updated 2026-10-20
NCT07255066
Optimizing Patient Treatment With EPA-enriched Nutrition, a Randomised Control Trial
Trial Treatment · University of Edinburgh
Oslo University Hospital, Oslo
Registry updated 2026-10-20
2025-522818-23-00
A Study to Test How Well ZL-1310 may Work Compared to Therapies Selected by the Investigator in Treating Patients with Relapsed Small Cell Lung Cancer
Trial Treatment · Phase 3 · Zai Lab (US) LLC
Vestre Viken HF, Drammen · Innlandet Hospital Health Authority, Gjoevik · Oslo Universitetssykehus HF, Oslo
Registry updated 2026-10-19
NCT06312137
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Sykehuset Innlandet HF, Brumunddal · Vestre Viken HF, Drammen · Akershus University Hospital, Loerenskog · Oslo University Hospital HF, Oslo
Registry updated 2026-10-15
2025-521908-22-00
IZABRIGHT-Lung01: Study of Izalontamab Brengitecan (BMS-986507) versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer after failure of EGFR TKI Therapy
Trial Treatment · Phase 2/3 · Bristol-Myers Squibb Services Unlimited Company
Helse Bergen HF, Bergen · Vestre Viken HF, Drammen · Oslo University Hospital HF, Oslo
Registry updated 2026-10-13
NCT07100080
Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)
Trial Treatment · Phase 2/3 · Bristol-Myers Squibb
Bergen · Drammen · Oslo
Registry updated 2026-10-09
NCT05739331
Augmented Endobronchial Ultrasound (EBUS-TBNA) With Artificial Intelligence
Research · Norwegian University of Science and Technology
Department of Pulmonology, Levanger Hospital, North Trøndelag Hospital Trust, Levanger · Department of Thoracic Medicine, St Olavs Hospital, Trondheim
Registry updated 2026-09-30
2025-524439-38-00
A phase II randomised trial investigating the benefit of adjuvant immunotherapy after neoadjuvant chemoimmunotherapy for resectable NSCLC (ADIL)
Trial Treatment · Phase 2 · Oslo Universitetssykehus HF
Helse Bergen HF, Bergen · Akershus University Hospital, Lorenskog · Oslo Universitetssykehus HF, Oslo · Universitetssykehuset Nord-Norge HF, Tromsoe · St. Olavs hospital HF, Trondheim
Registry updated 2026-09-28
NCT06038227
Lung cAncer Robotic Comparative Study
Research · Intuitive Surgical
Akershus University Hospital, Loerenskog
Registry updated 2026-09-14
2024-515884-69-00
Study of Sacituzumab Govitecan Versus Standard of Care in Participants with Previously Treated Extensive Stage Small Cell Lung Cancer
Trial Treatment · Phase 3 · Gilead Sciences Inc.
Helse Bergen HF, Bergen · Vestre Viken HF, Drammen · Oslo University Hospital HF, Oslo
Registry updated 2026-08-31
2026-525513-31-00
Does a higher radiation dose prolong survival of patients with limited-stage small cell lung cancer receiving immunotherapy after chemotherapy and radiation therapy (DAHRTS trial)?
Trial Treatment · Phase 3 · Norges Teknisk-Naturvitenskapelige Universitet NTNU
Helse Moere Og Romsdal HF, Aalesund · Helse Bergen HF, Bergen · Nordlandssykehuset HF, Bodo · Vestre Viken HF, Drammen · Helse Fonna HF, Haugesund · Sorlandet Sykehus HF, Kristiansand S · Helse Nord-Trondelag HF, Levanger · Akershus University Hospital, Lorenskog · Oslo Universitetssykehus HF, Oslo · Helse Stavanger HF, Stavanger · Universitetssykehuset Nord-Norge HF, Tromsoe · St. Olavs hospital HF, Trondheim
Registry updated 2026-08-24
NCT07301489
Akershus Cardiac Examination (ACE) 5 Study
Trial Treatment · University Hospital, Akershus
Akershus University Hospital, Lørenskog
Registry updated 2025-12-24
2023-510089-28-00
COMBINATORY IMMUNOTHERAPY-2 (COM-IT-2) A phase 2 randomised open two-arm study to assess the tolerability and efficacy of immunotherapy combined with extensive radiotherapyfor the treatment of stage IV non-small cell lung cancer
Trial Treatment · Phase 1/2 · Oslo University Hospital HF
Sykehuset Innlandet HF, Gjoevik · Oslo University Hospital HF, Oslo · St. Olavs hospital HF, Trondheim
Registry updated 2025-06-20
NCT05344209
Efficacy and Safety of Anti-PD-1/PD-L1 Treatment +/- UV1 Vaccination in Patients With Non-small Cell Lung Cancer
Trial Treatment · Phase 2 · Vestre Viken Hospital Trust
Sykehuset Innlandet HF, Brumunddal · Vestre Viken HF, Drammen · Helse Forde HF, Foerde · Nord-Trondelag Hospital Trust, Levanger · Akershus University Hospital, Loerenskog · Oslo University Hospital HF, Oslo · Helse Stavanger HF, Stavanger · University Hospital Of North Norway HF, Tromsoe · St. Olavs hospital HF, Trondheim
Registry updated 2023-11-09

All Lung cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error